Clinical trials
Phase 2 Acromegaly trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Terminated | 4 |
| Unknown status | 2 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Crinetics Pharmaceuticals Inc. | 3 |
| Ionis Pharmaceuticals, Inc. | 3 |
| Ipsen | 3 |
| Novartis Pharmaceuticals | 3 |
| Aspireo Pharmaceuticals Limited | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Andrea M. Isidori | 1 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 1 |
| Camurus AB | 1 |
| Endo USA Inc., a Keenova Therapeutics Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acromegaly | 25 |
| Pituitary Neoplasms | 2 |
| Gigantism | 1 |
| Growth Disorders | 1 |
| Hypertrophy, Left Ventricular | 1 |
| Neuroendocrine Tumors | 1 |
| Serotonin Syndrome | 1 |
Trials
Showing 76 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.